Neuroglee bags US$2.3M in pre-seed funding to strengthen fight against Alzheimer’s

Neuroglee Therapeutics, a Singapore-based healthtech startup building evidence-based, prescription digital therapeutics for neurodegenerative diseases, announced today that it has raised US$2.3 million in pre-seed funding. The round was led by Eisai, a Japanese global pharmaceutical company. Kuldeep Singh Rajput, Founder & CEO of Biofourmis, also participated in the investment round.  As per a press note, […] The post Neuroglee bags US$2.3M in pre-seed funding to strengthen fight against Alzheimer’s appeared first on e27.